JUPITER LIFE LINE HOSP L (JLHL) financials
JUPITER LIFE LINE HOSP L (JLHL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap: ₹8,099Cr.
- Current Price: ₹247
- Stock P/E: 43.0
- ROE: 12.1%
- ROCE: 15.0%
- Book Value: ₹49.0
- Dividend Yield: 0.08%
- 52W High / Low: ₹340/230
In Jun 2026, JUPITER LIFE LINE HOSP L (JLHL) reported sales ₹328 Cr and net profit ₹37 Cr.
Annual TTM: sales ₹1,248 Cr, net profit ₹185 Cr.
Shareholding: Promoters 40.91% (Sep 2026), FIIs 9.13% (Sep 2026), DIIs 19.13% (Sep 2026), Public 30.85% (Sep 2026), No. of Shareholders 33,255% (Sep 2026).
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 275 | 270 | 274 | 278 | 316 | 291 | 312 | 328 |
| Expenses | 204 | 202 | 202 | 210 | 237 | 216 | 234 | 259 |
| Operating Profit | 71 | 69 | 72 | 68 | 79 | 76 | 78 | 69 |
| OPM % | 26% | 25% | 26% | 24% | 25% | 26% | 25% | 21% |
| Other Income | 7 | 7 | 7 | 13 | 11 | 4 | 10 | 11 |
| Interest | 1 | 3 | 4 | 3 | 3 | 3 | 4 | 8 |
| Depreciation | 10 | 11 | 13 | 17 | 17 | 17 | 18 | 22 |
| Profit before tax | 67 | 62 | 62 | 61 | 70 | 60 | 66 | 50 |
| Tax % | 25% | 21% | 28% | 29% | 23% | 26% | 25% | 26% |
| Net Profit | 50 | 49 | 44 | 43 | 55 | 44 | 49 | 37 |
| EPS in Rs | 1.53 | 1.50 | 1.36 | 1.32 | 1.67 | 1.35 | 1.50 | 1.13 |
| Raw PDF | — | — | — | — | — | — | — | — |
| Category | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 463 | 461 | 657 | 787 | 915 | 1,060 | 1,198 | 1,248 |
| Expenses | 380 | 392 | 498 | 583 | 687 | 788 | 897 | 946 |
| Operating Profit | 83 | 69 | 159 | 204 | 227 | 272 | 300 | 302 |
| OPM % | 18% | 15% | 24% | 26% | 25% | 26% | 25% | 24% |
| Other Income | 2 | 4 | 4 | 11 | 26 | 25 | 38 | 36 |
| Interest | 26 | 28 | 29 | 28 | 19 | 9 | 13 | 18 |
| Depreciation | 26 | 27 | 28 | 29 | 31 | 42 | 69 | 74 |
| Profit before tax | 33 | 18 | 106 | 159 | 204 | 246 | 257 | 246 |
| Tax % | 10% | 5% | 20% | 33% | 25% | 25% | 25% | — |
| Net Profit | 30 | 17 | 85 | 107 | 152 | 185 | 191 | 185 |
| EPS in Rs | 1.17 | 0.65 | 3.33 | 3.79 | 4.64 | 5.63 | 5.84 | 5.65 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 4% | 4% | 3% | — |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 51 | 51 | 51 | 51 | 57 | 66 | 66 | 66 |
| Reserves | 162 | 186 | 202 | 278 | 409 | 1,180 | 1,357 | 1,542 |
| Borrowings | 252 | 263 | 262 | 322 | 298 | 0 | 142 | 335 |
| Other Liabilities | 71 | 94 | 100 | 104 | 123 | 115 | 153 | 218 |
| Total Liabilities | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,718 | 2,160 |
| Fixed Assets | 431 | 435 | 426 | 465 | 476 | 477 | 713 | 1,123 |
| CWIP | 12 | 10 | 13 | 14 | 16 | 61 | 163 | 113 |
| Investments | 2 | 2 | 65 | 71 | 95 | 111 | 606 | 580 |
| Other Assets | 92 | 146 | 109 | 205 | 297 | 711 | 236 | 344 |
| Total Assets | 537 | 594 | 615 | 755 | 885 | 1,361 | 1,718 | 2,160 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 46 | 75 | 113 | 142 | 184 | 110 | 219 | 231 |
| Cash from Investing Activity | -58 | -43 | -78 | -68 | -130 | -238 | -455 | -423 |
| Cash from Financing Activity | 16 | -32 | -23 | 10 | -23 | 122 | 302 | 145 |
| Net Cash Flow | 3 | -1 | 12 | 84 | 31 | -6 | 66 | -47 |
| Free Cash Flow | -15 | 46 | 91 | 76 | 141 | 34 | -62 | -252 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 92% | 109% | 181% | 95% | 107% | 70% | 103% | 97% |
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| FIIs | 10.04% | 10.04% | 9.77% | 9.06% | 8.48% | 8.48% | 9.37% | 9.13% |
| DIIs | 15.75% | 15.64% | 15.82% | 16.97% | 17.44% | 17.01% | 16.51% | 19.13% |
| Public | 33.31% | 33.43% | 33.51% | 33.08% | 33.17% | 33.60% | 33.20% | 30.85% |
| No. of Shareholders | 33,914 | 33,956 | 34,192 | 34,361 | 33,620 | 32,985 | 33,194 | 33,255 |
| Category | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 24 | 35 | 16 | 15 | 19 | 18 | 13 | 20 |
| Inventory Days | 46 | 64 | 45 | 38 | 42 | 39 | 35 | 49 |
| Days Payable | 168 | 268 | 192 | 155 | 169 | 116 | 103 | 124 |
| Cash Conversion Cycle | -98 | -169 | -132 | -101 | -108 | -59 | -56 | -55 |
| Working Capital Days | 11 | 36 | 1 | -18 | -18 | -7 | -12 | -12 |
| ROCE % | 10% | 12% | 9% | 23% | 27% | 22% | 18% | 15% |
Jupiter Life Line Hosp L
₹8,099Cr.
₹247
₹340/230
43.0
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
Quarterly results
Profit & loss
Shareholding trend
Balance sheet
Cash flows
Key ratios
Frequently asked questions
What is the market cap of JUPITER LIFE LINE HOSP L (JLHL)?
The reported market capitalisation for JUPITER LIFE LINE HOSP L (JLHL) is ₹8,099Cr. on Fincrux. Figures may update with market data and filings.
What is the current share price of JLHL?
The current price shown for JUPITER LIFE LINE HOSP L (JLHL) on Fincrux is ₹247 with a 52-week high/low of ₹340/230.
What is the P/E ratio of JUPITER LIFE LINE HOSP L (JLHL)?
The stock P/E for JUPITER LIFE LINE HOSP L (JLHL) is 43.0 on Fincrux, with ROE at 12.1% and ROCE at 15.0%.
What were JLHL latest quarterly results?
For Jun 2026, JUPITER LIFE LINE HOSP L (JLHL) reported sales ₹328 Cr and net profit ₹37 Cr (figures in ₹ crore unless noted).
What are JLHL annual sales and net profit?
For TTM, JUPITER LIFE LINE HOSP L (JLHL) shows sales of ₹1,248 Cr and net profit of ₹185 Cr on the Fincrux profit & loss statement.
Who owns JUPITER LIFE LINE HOSP L (JLHL)?
Latest shareholding for JUPITER LIFE LINE HOSP L (JLHL) on Fincrux: Promoters 40.91% (Sep 2026), FIIs 9.13% (Sep 2026), DIIs 19.13% (Sep 2026), Public 30.85% (Sep 2026), No. of Shareholders 33,255% (Sep 2026).
Where can I find JUPITER LIFE LINE HOSP L (JLHL) financials?
JUPITER LIFE LINE HOSP L (JLHL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.
Does Fincrux show JLHL balance sheet and cash flow?
Yes. The JUPITER LIFE LINE HOSP L (JLHL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.